Monitor for future financial disclosures on IME's revenue contribution and any accretion/dilution. The acquisition is small and unlikely to move THRM materially in the near term.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 23 $45.61entry
- T+1 · 4mo ago −6.40%α −6.50% · $42.69
- T+5 · 4mo ago −7.21%α −7.69% · $42.32
- T+20 · 3mo ago −10.81%α −14.12% · $40.68
- T+60 · 5w ago −34.64%α −39.19% · $29.81
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Gentherm acquired Innovative Medical Equipment (IME), a provider of the ThermaZone thermal therapy device, to expand its Medical business. The deal value was not disclosed, and the acquisition appears small relative to Gentherm's ~$1.5B annual revenue, making it a routine bolt-on acquisition with limited near-term financial impact.
Key Facts
- Acquired Innovative Medical Equipment (IME), maker of the ThermaZone non-opioid thermal therapy device.
- Deal value not disclosed; expected to be immaterial given Gentherm's ~$1.5B annual sales.
- Acquisition supports Gentherm's strategy to strengthen its Medical business and expand product portfolio.
- ThermaZone is a controlled hot-and-cold therapy solution for pain management and recovery.
Financial Impact
Undisclosed; likely immaterial relative to Gentherm's ~$1.5B annual revenue.
Risk Factors
- Integration risk if IME's operations do not align with Gentherm's global model.
- No financial details provided, making it difficult to assess value creation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3331679 |
Track record
25 reports on THRM
2 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.29% at T+60 after the Apr 23, 2026 report. 5 of 9 went positive at some point.
Filters
- Oct 26, 202621d ago Insider Cluster Bullish 4/10 Entry $31.82 Now $28.53 −10.34% settles Nov 24
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $26.15 Now $28.53 −9.10% settles Nov 19
- Oct 9, 20265w ago 8-K/A Neutral 5/10 Entry $30.92 to $30.38 Now $28.53 −7.73% ▼ −1.75% +1.52% vs SPY
- Oct 6, 20265w ago 3 Neutral 2/10 Entry $30.38 to $31.11 Now $28.53 −6.09% ▲ +2.40% +3.74% vs SPY
- Oct 1, 20266w ago 8-K Neutral 6/10 Entry $31.30 to $30.95 Now $28.53 −8.85% ▼ −1.12% +0.69% vs SPY
- Oct 1, 20266w ago Press Release Neutral 5/10 Entry $31.30 to $30.95 Now $28.53 −8.85% ▼ −1.12% +0.69% vs SPY
- Sep 17, 20268w ago Press Release Neutral 5/10 Entry $36.35 to $29.04 Now $28.53 −21.51% ▼ −20.11% −20.31% vs SPY
- Sep 11, 20269w ago 8-K Bullish 6/10 Entry $38.85 to $29.68 Now $28.53 −26.56% ▼ −23.60% −25.47% vs SPY
- Sep 10, 20269w ago Press Release Bullish 7/10 Entry $38.33 to $29.93 Now $28.53 −25.57% ▼ −21.91% −24.04% vs SPY
- Aug 13, 202613w ago EFFECT Neutral 3/10 Entry $43.07 to $38.85 Now $28.53 −33.76% ▼ −9.80% −8.05% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers